Atopic Dermatitis: What's Best Treatment Practice?

Video
Conference|Maui Derm NP+PA Summer

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.

Related Videos
Related Content

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

September 22nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

September 19th 2023

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

September 19th 2023

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

September 22nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

September 19th 2023

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

September 19th 2023

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

September 22nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

September 19th 2023

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

September 19th 2023
© 2023 MJH Life Sciences

All rights reserved.